These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22096929)

  • 21. Therapy of hepatitis C: other options.
    Bonkovsky HL
    Hepatology; 1997 Sep; 26(3 Suppl 1):143S-151S. PubMed ID: 9305680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron depletion and response to interferon in chronic hepatitis C.
    Carlo C; Daniela P; Giancarlo C
    Hepatogastroenterology; 2003; 50(53):1467-71. PubMed ID: 14571765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron.
    Hayashi H; Takikawa T; Nishimura N; Yano M; Isomura T; Sakamoto N
    Am J Gastroenterol; 1994 Jul; 89(7):986-8. PubMed ID: 8017395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic hepatitis. 5: Therapy of chronic viral hepatitis, especially hepatitis C].
    Schlaak JF; Gerken G
    Fortschr Med; 1997 Sep; 115(25):48-50. PubMed ID: 9378444
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of iron depletion on long-term response to interferon in patients with chronic hepatitis C with increased plasma iron without accumulation of liver iron].
    Cagnoni C; Corsini F; Pancotti D; Carrara G
    Ann Ital Med Int; 2000; 15(2):132-8. PubMed ID: 10920503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
    Hicken BL; Tucker DC; Barton JC
    Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of chronic hepatitis B and C].
    Müllhaupt B; Renner EL
    Praxis (Bern 1994); 1999 Apr; 88(14):619-32. PubMed ID: 10321122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron as a comorbid factor in chronic viral hepatitis.
    Bonkovsky HL
    Am J Gastroenterol; 2002 Jan; 97(1):1-4. PubMed ID: 11808931
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial.
    Lainé F; Reymann JM; Morel F; Langouët S; Perrin M; Guillygomarc'h A; Brissot P; Turmel V; Mouchel C; Pape D; Bellissant E; Deugnier Y
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1207-13. PubMed ID: 17014579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?].
    Larrey D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B283-90. PubMed ID: 12180302
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic hepatitis C infection. A disease ideally suited to management in the primary care setting.
    Dore GJ
    Aust Fam Physician; 1998 Sep; 27(9):791-3. PubMed ID: 9769526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon treatment of children with chronic hepatitis C.
    al-Tawil Y; Nelson C
    Hepatogastroenterology; 1998; 45(20):345-8. PubMed ID: 9638404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic hepatitis B, hemosiderosis, and hepatic fibrosis in a renal graft recipient].
    Zubkin ML; Pavlov ChS; Chervinko VI; Semenenko TA; Balakirev EM; Zolotarevskiĭ VB; Frolov AV; Baranova FS; Repetiĭ NG; Bakulin IG; Stanke AA; Novozhenov VG
    Klin Med (Mosk); 2009; 87(6):64-7. PubMed ID: 19670722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autoimmune hepatitis and chronic hepatitis C].
    Czerwionka-Szaflarska M; Zyromska A; Szaflarska-Szczepanik A
    Pol Merkur Lekarski; 1997 Nov; 3(17):221-3. PubMed ID: 9523476
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel treatment of patients with chronic hepatitis C.
    Tsai NC; Shimoda N; Wong L; Shimoda S; Goad K; Yee H; Chen M
    Hawaii Med J; 1999 Apr; 58(4):85-8. PubMed ID: 10363429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis and treatment of autoimmune hepatitis and chronic viral hepatitis B and C.
    Pár A
    Acta Physiol Hung; 2000; 87(4):373-95. PubMed ID: 11732890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C.
    Tanaka H; Shiota G; Kawasaki H
    J Med; 1997; 28(5-6):335-46. PubMed ID: 9604792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic viral hepatitis therapy in a new era - the importance of genotyping.
    Diculescu M; Ciocîrlan M; Ciocîrlan M
    Rom J Gastroenterol; 2004 Jun; 13(2):167-8. PubMed ID: 15229783
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chronic hepatitis C in children: are extrahepatic manifestations an argument for standard therapy?].
    Azoicăi AN; Moraru E
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1035-41. PubMed ID: 21500456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus: a critical appraisal of approaches to therapy.
    Nelson DR; Davis GL; Jacobson I; Everson GT; Fried MW; Harrison SA; Hassanein T; Jensen DM; Lindsay KL; Terrault N; Zein N
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):397-414; quiz 366. PubMed ID: 19114127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.